Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Novo Nordisk A/S (NVO) had Non-Operating Income/Expense of $122.45M for the most recently reported fiscal quarter, ending 2023-12-31.
Income Statement Financials | |
$9.53B |
|
$3.18B |
|
$1.45B |
|
$8.08B |
|
$5.66B |
|
$3.87B |
|
Non-Operating Income/Expense |
$122.45M |
$3.99B |
|
$3.99B |
|
$3.18B |
|
$3.18B |
|
$3.18B |
|
$3.18B |
|
$3.87B |
|
$4.30B |
|
4.48B |
|
4.49B |
|
$0.71 |
|
$0.71 |
|
Balance Sheet Financials | |
$20.28B |
|
$13.21B |
|
$25.39B |
|
$45.66B |
|
$24.63B |
|
$2.98B |
|
$5.56B |
|
$30.19B |
|
$15.47B |
|
$6.70B |
|
$15.47B |
|
4.51B |
|
Cash Flow Statement Financials | |
$15.81B |
|
$-6.37B |
|
$-9.17B |
|
$1.84B |
|
$2.09B |
|
$252.50M |
|
$312.03M |
|
$-4.61B |
|
-- |
|
Fundamental Metrics & Ratios | |
0.82 |
|
-- |
|
-- |
|
0.16 |
|
0.25 |
|
84.80% |
|
40.63% |
|
40.63% |
|
-- |
|
41.92% |
|
33.33% |
|
$12.07B |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
0.31 |
|
0.87 |
|
103.24 |
|
20.52% |
|
47.38% |
|
6.95% |
|
17.21% |
|
$3.43 |
|
$2.68 |
|
$3.52 |